Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-008290

Options or other derivatives

  • CEO acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pershing Edward CEO 2026-02-26 Grant or award · 8% Unsecured Convertible Promissory Note +0 D: show line 1 in the form
Loading xslF345X05/ownership.xml…